Insider Transactions in Q3 2020 at Amicus Therapeutics, Inc. (FOLD)
Insider Transaction List (Q3 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2020
|
Jay Barth Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,064
-2.43%
|
$56,896
$14.51 P/Share
|
|
Sep 30
2020
|
Jay Barth Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,064
+2.37%
|
$8,128
$2.29 P/Share
|
|
Sep 28
2020
|
Bradley L Campbell President and CEO |
SELL
Open market or private sale
|
Direct |
24,782
-6.82%
|
$322,166
$13.89 P/Share
|
|
Sep 28
2020
|
Bradley L Campbell President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,782
+6.38%
|
$49,564
$2.52 P/Share
|
|
Aug 17
2020
|
Samantha Prout Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,181
+31.67%
|
-
|